Printer-friendly versionPrinter-friendly version

Prevention and control of Viral Hepatitis in Belgium and Luxembourg: lessons learnt and the way forward.

7-8 November 2017 - Brussel, Belgium

Meeting objectives:

  • Provide an overview of surveillance systems for infectious diseases;
  • Review the epidemiological situation on viral hepatitis;
  • Give an overview of the current prevention and control measures on viral hepatitis;
  • Review the possible implementation of new prevention strategies, control measures and monitoring systems;
  • Discuss the development, the enrolment and the implementation of a National hepatitis plan;
  • Assess the needs to achieve the goal of eliminating viral hepatitis as a major public health threat by 2030 as defined by WHO’s Regional office for Europe;
  • Discuss successes, issues and barriers to overcome, and the way forward.

Background document  - 2.9 Mb (.pdf)

Thursday 01 June

SESSION 1: OPENING AND OBJECTIVES
Chairs: Pierre Van Damme and Tatjana Reic

09:00-09:30

  • Welcome and opening
  • Introduction of the participants
  • Introduction of the VHPB
  • Objectives of the meeting:
  • Review of the meeting programme

SESSION 2: THE HEALTH CARE SYSTEM IN BELGIUM _ LUXEMBOURG

09:30 - 09:50 Belgium
Lieven De Raedt

09:50 - 10:10 Luxembourg - 810 kb (.pdf)
Jean-Claude Schmit

10:10 - 10:30 Questions and discussion

10:30 - 10:50 Coffee break

SESSION 2: SURVEILLANCE SYSTEM AND EPIDEMIOLOGY IN BELGIUM AND LUXEMBOURG
Chairs: Erika Duffell – Vladimir Chulanov

10:50 - 11:10 Overview of surveillance system and epidemiology of hepatitis A, D and E -  636 kb (.pdf)
Steven Van Gucht

11:10 - 11:30 Overview of surveillance system and epidemiology of hepatitis B and C -  569 kb (.pdf)
Gaëtan Muyldermans

11:30 - 11:50 Overview of surveillance and epidemiology in Luxembourg -  1.4 Mb (.pdf)
Carole Devaux

11:50 - 12:10 Questions and discussion

SESSION 4: VIRAL HEPATITIS DISEASE BURDEN

12:10 - 12:30 Chronic viral hepatitis and liver disease in Belgium - 2 Mb (.pdf)
Pierre Deltenre

12:30- 12:50 Chronic viral hepatitis and liver disease in Luxembourg - 967 kb (.pdf)
Carole Devaux

12:50 - 13:10 Discussion

13:10 – 14:10 Lunch

 

SESSION 5: PREVENTION OF VIRAL HEPATITIS
Chairs: Daniel Shouval and Vana Papaevangelou

14:10 - 14:40 Vaccination program in Belgium (Wallonia) - 569 kb (.pdf)
Ingrid Morales

14:10 - 14:40 Vaccination program in Belgium (Flanders) - 1 Mb (.pdf)
Geert Top

14:40- 15:00 Vaccination program in Luxembourg - 305 kb (.pdf)
Françoise Berthet

15:00- 15:20 Clinics, Treatment and Prevention of viral hepatitis E. - 2.5 Mb (.pdf)
Thomas Vanwolleghem

15:20- 15:40 Hepatitis A outbreak: epidemiology and management - 1.1 Mb (.pdf)
Naïma Hammami

15:40 - 16:00 Questions & Comments

16:00- 16:20 Coffee break

 

SESSION 6: EPIDEMIOLOGY, PREVENTION AND CONTROL OF VIRAL HEPATITIS IN DIFFERENT RISK GROUPS
Chairs: Daniel Lavanchy and Heléne Norder

16:20 - 16:40 Prevention and control of viral hepatitis in IDU/prisoners - Belgium - 1.3 Mb (.pdf)
Cathy Matheï

16:40 - 17:00 Prevention and control of viral hepatitis in IDU/prisoners - Luxembourg - 2.1 Mb (.pdf)
Patrick Hoffmann

17:00 - 17:20 Screening and prevention of viral hepatitis in sex workers - 957 kb (.pdf)
Heleen Van Mieghem

17:20- 17:40 Do or don’t screen - Migrants: hepatitis B and C in Chinese population in Antwerp
Erwin Ho

17:40 – 18:00 Questions and comments

 

Wednesday 08 November

SESSION 7: CONTROL – TREATMENT VIRAL HEPATITIS IN BELGIUM -LUXEMBOURG
Chairs: Mojca Matičič – Francoise Roudot- Thoraval

08:30 – 08:50 BASL Treatment guidelines for viral hepatitis B/C - 620 kb (.pdf)
Anja Geerts (BASL)

08:50 – 09:10 Treatment habits and recommandations in Luxembourg - 1.6 Mb (.pdf)
Victor Arendt

09:10 – 09:30 Questions and comments

SESSION 8: NATIONAL HEPATITIS PLAN _ POLICIES

09:30 - 09:50 National Hepatitis plan - Belgium - 1.6 Mb (.pdf)
Jean-Pierre Mulkay

09:50 - 10:10 National Hepatitis plan - Luxembourg - 671 kb (.pdf)
Victor Arendt

10:10 - 10:30 Do or don't screen - screening in hospital emergency service
Rob Bielen

10:30 - 10:50 Questions and discussion

10:50 - 11:15 Coffee break

SESSION 9: GROUP DISCUSSION: WHAT ARE THE NEEDS TO ELIMINATE VIRAL HEPATITIS BY 2030

11:15 - 11:35 Achieving WHO recommendations for Hepatitis C Virus Elimination in Belgium - The disease burden of hepatitis C in Belgium: an update of a realistic disease control strategy - 1 Mb (.pdf)
Peter Stärkel

11:35 - 12:45 Discussion groups

12:45 - 13:15 Presentation of the results of the discussion groups

  • Group 1
  • Group 2
  • Group 3
  • Group 4

13:15 – 13:30 Questions and comments

13:30 – 14:45 Lunch

SESSION 10: CONCLUSIONS
Chairs: Mark Kane - Alessandro Zanetti

14:45– 15:35 VHPB meeting conclusions.
David FitzSimons

Tags: